Bangladesh approves Oxford-AstraZeneca vaccine
The Beximco Pharmaceuticals Ltd. has received formal approval from the Directorate General of Drug Administration (DGDA) to import Covid vaccine developed by Oxford-AstraZeneca.
Ayub Hossain, spokesperson of the DGDA, confirmed the information to The Business Standard. He said there is now no obstacle from Bangladesh's side to import the vaccine and use it in emergency cases.
The development came within hours after Beximco had applied for the authorisation of emergency use of the vaccine in Bangladesh on Monday noon.
Keep updated, follow The Business Standard's Google news channel
Beximco has a deal with Serum Institute of India to import the Covid vaccine developed by Oxford University and AstraZeneca.
However, the deal apparently confronted a major setback yesterday when the Indian authority had reportedly banned the commercial export of Oxford-AstraZeneca vaccine.
Even though ministers as well as top officials of Beximco came up optimistic and reassured that the reported ban will not affect the deal.
The Indian pharmaceutical company is bound to fulfill the agreement and Bangladesh will get the vaccine in due time.
